Consainsights logo
Reports > Life Sciences > Single Use Bioprocessing Market Report

Single Use Bioprocessing Market Size, Share, Industry Trends and Forecast to 2033

This report provides a comprehensive analysis of the Single Use Bioprocessing market, covering insights on market size, trends, and growth forecasts from 2023 to 2033. It aims to deliver an in-depth understanding of market dynamics and segments reshaping the industry landscape.

Metric Value
Study Period 2023 - 2033
2023 Market Size $5.20 Billion
CAGR (2023-2033) 9.5%
2033 Market Size $13.30 Billion
Top Companies Thermo Fisher Scientific, Sartorius AG, Pall Corporation, DANAHER Corporation
Last Modified Date 15 Nov 2024

Single Use Bioprocessing Market Report (2023 - 2033)

Single Use Bioprocessing Market Overview

The Single Use Bioprocessing industry is characterized by its dynamic growth driven by innovative technological enhancements and a growing demand for biopharmaceuticals. Factors such as a surge in vaccine demand and advancements in biologics development significantly influence market trends. Moreover, companies are increasingly investing in research and development to enhance the functionality of single-use products. Regulatory support for biopharmaceutical innovations further bolsters market growth. Companies are closely monitoring sustainability concerns which are leading them to innovate eco-friendly single-use solutions, aligning with the wider sustainability trends across industries.

What is the Market Size & CAGR of Single Use Bioprocessing market in 2023?

In 2023, the Single Use Bioprocessing market size is approximately $3.21 billion, and it is expected to witness a compound annual growth rate (CAGR) of around 12.5% between 2023 and 2033. This impressive growth can be attributed to the increasing adoption of single-use technologies in biopharmaceutical processes aimed at increasing efficiency while reducing operational costs. By 2033, the market is projected to reach approximately $8.22 billion, highlighting significant opportunities for manufacturers and service providers in this evolving space.

Single Use Bioprocessing Industry Analysis

The Single Use Bioprocessing industry is characterized by its dynamic growth driven by innovative technological enhancements and a growing demand for biopharmaceuticals. Factors such as a surge in vaccine demand and advancements in biologics development significantly influence market trends. Moreover, companies are increasingly investing in research and development to enhance the functionality of single-use products. Regulatory support for biopharmaceutical innovations further bolsters market growth. Companies are closely monitoring sustainability concerns which are leading them to innovate eco-friendly single-use solutions, aligning with the wider sustainability trends across industries.

Single Use Bioprocessing Market Segmentation and Scope

The Single Use Bioprocessing market is primarily segmented by product types, applications, and end-users. Key segments include bags and containers, filters, valves and tubing, and other accessories, which collectively simplify biopharmaceutical manufacturing processes. Applications range from vaccine production and monoclonal antibody production to cellular therapy and regulatory compliance. Moreover, end-users include biopharmaceutical companies, contract manufacturing organizations, and research institutes. The diverse segments indicate vital roles in adapting to market demands, technological advancements, and regulatory changes, contributing to the overall growth of the industry.

Request a custom research report for industry.

Single Use Bioprocessing Market Analysis Report by Region

Europe Single Use Bioprocessing Market Report:

Europe is predicted to experience robust growth, with the market size expanding from $1.33 billion in 2023 to $3.40 billion by 2033, driven by significant advancements in biopharmaceutical research and increased acceptance of single-use technologies.

Asia Pacific Single Use Bioprocessing Market Report:

The Asia Pacific region is poised for significant growth in the Single Use Bioprocessing market, with a projected market size increasing from $1.02 billion in 2023 to $2.60 billion by 2033. Rising investments in biotechnology and an expanding pharmaceutical industry drive demand in this region.

North America Single Use Bioprocessing Market Report:

North America leads the Single Use Bioprocessing market, forecasted to grow from $1.76 billion in 2023 to $4.50 billion by 2033. This growth can be attributed to the presence of numerous established biopharmaceutical companies and advanced infrastructure supporting bioprocessing.

South America Single Use Bioprocessing Market Report:

In South America, the market size is expected to evolve from $0.46 billion in 2023 to $1.17 billion by 2033, showcasing increased adoption of innovative bioprocessing technologies among local players emphasizing cost efficiency.

Middle East & Africa Single Use Bioprocessing Market Report:

The Middle East and Africa region's market is expected to increase from $0.64 billion in 2023 to $1.64 billion by 2033, largely supported by improving healthcare infrastructure and rising investments in bioprocessing capabilities.

Request a custom research report for industry.

Single Use Bioprocessing Market Analysis By Product

Global Single-Use Bioprocessing Market, By Product Market Analysis (2023 - 2033)

The product segment of the Single Use Bioprocessing market is dominated by Bags and Containers, projected to increase from $3.21 billion in 2023 to $8.22 billion by 2033, holding a 61.77% market share. Filters, valued at $1.33 billion in 2023, will climb to $3.41 billion, maintaining a 25.66% share. Valves and Tubing are anticipated to grow from $0.65 billion to $1.67 billion, contributing to 12.57% market share.

Single Use Bioprocessing Market Analysis By Application

Global Single-Use Bioprocessing Market, By Application Market Analysis (2023 - 2033)

In the application segment, Vaccine Manufacturing is a predominant driver, expected to see growth from $2.84 billion in 2023 to $7.26 billion by 2033, representing 54.55% market share. Monoclonal Antibody Production and Cellular Therapy are also key segments, with market sizes of $1.19 billion and $0.59 billion in 2023, respectively.

Single Use Bioprocessing Market Analysis By End User

Global Single-Use Bioprocessing Market, By End-User Market Analysis (2023 - 2033)

Biopharmaceutical Companies are the leading end-users, with an expected share rising to 61.77% by 2033. Contract Manufacturing Organizations and Research Institutes hold shares of 25.66% and 12.57%, respectively, reflecting the collaboration between industry players to enhance capabilities.

Single Use Bioprocessing Market Analysis By Region Circular Economy

Global Single-Use Bioprocessing Market, By Region Considerations Market Analysis (2023 - 2033)

Regional factors play a crucial role in shaping the Single Use Bioprocessing market, with a focus on sustainability making significant inroads across all regions. There’s a push for circular economy practices in North America and Europe, while emerging markets in Asia and South America are adapting rapid innovations aligned with international best practices.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Single Use Bioprocessing Industry

Thermo Fisher Scientific:

A key player in the life sciences sector, Thermo Fisher Scientific is known for its innovations in bioprocessing technologies, offering a wide range of single-use products to enhance manufacturability in biopharmaceutical production.

Sartorius AG:

Sartorius AG is recognized for its sophisticated bioprocess solutions, including single-use systems that improve efficiency for biopharmaceutical manufacturers and ensure product integrity.

Pall Corporation:

Pall Corporation provides comprehensive filtrations, purification, and separations solutions for bioprocessing applications, leading the market with a strong focus on single-use technologies.

DANAHER Corporation:

DANAHER Corporation’s Life Sciences division delivers a range of single-use bioprocessing solutions that advance the production of biologics while maintaining compliance with evolving regulatory standards.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs